Sartorius AG SARTORIUS PREF SHS
Sartorius AG SARTORIUS PREF SHS/ DE0007165631 /
0NIR
|
5/24/2024 6:35:16 PM
|
Chg.
-
|
Volume |
Bid5:40:08 PM |
Ask5:40:08 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
254.45EUR
|
-
|
11,663
Turnover: 2.46 mill. |
-Bid Size: - |
-Ask Size: - |
13.3 bill.EUR |
0.34% |
71.77 |
Business description
The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes.
Management board & Supervisory board
| CEO |
| Joachim Kreuzburg |
| Management board |
| Rainer Lehmann, Dr. René Fáber, Gerry MacKay, Alexandra Gatzemeyer |
| Supervisory board |
| Dr. Lothar Kappich, Manfred Zaffke, Prof. David Raymond Ebsworth, Dr. Daniela Favoccia, Petra Kirchhoff, Dietmar Müller, Ilke Hildegard Panzer, Frank Riemensperger, Hermann Jens Ritzau, Prof. Dr. Klaus Rüdiger Trützschler, Sabrina Wirth |
Company data
| Name: |
Sartorius AG |
| Address: |
Otto-Brenner-Str. 20,D-37079 Goettingen |
| Phone: |
+49-551-308-0 |
| Fax: |
+49-551-308-3289 |
| E-mail: |
info@sartorius.com
|
| Internet: |
www.sartorius.de |
| Industry: |
Technology |
| Sector: |
Other Technology Industries |
| Sub sector: |
- |
| End of financial year: |
12/31 |
| Free Float: |
40.81% |
| IPO date: |
7/10/1990 |
Main Shareholders
| FreeFloat |
|
72.00% |
| Bio-Rad Laboratories |
|
28.00% |
